|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02235 MICROTECH MED-B
Nominal 
7.400 +0.020 (+0.271%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 345,615 | 253,228 | 173,607 | 151,404 |
| Cost of Sales | -- | -- | -- | -- | -- | (80,521) |
| Gross Profit | -- | -- | -- | -- | -- | 70,883 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (5,120) | (4,528) | (4,944) | (1,229) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | (8) | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | (63,149) | (124,852) | (35,042) | (48,153) | |
| Taxation | -- | -- | 31 | (164) | (2) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 40,152 | -- | (63,118) | (125,016) | (35,043) | (48,153) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | (71,565) | (75,037) | (85,401) | (23,299) |
| Depreciation & Amortisation | -- | -- | 12,103 | 11,173 | 10,484 | 8,332 |
| Directors' Emoluments | -- | -- | 5,894 | 4,582 | 4,546 | 16,254 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 10.000 | -- | -15.000 | -29.000 | -8.000 | -13.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.288) | (0.359) | (0.280) | (0.118) |
| NBV per share ($) | -- | -- | 4.712 | 4.841 | 5.196 | 5.277 |
| Remarks: | Real time quote last updated: 02/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 40,152 |
| %Change | -- |
| EPS / (LPS) | RMB 0.100 |
| NBV Per Share (¥) | RMB -- |